Biotest AG (XTER:BIO) Buildings And Improvements : €0.0 Mil (As of Mar. 2024)

View and export this data going back to 1987. Start your Free Trial

What is Biotest AG Buildings And Improvements?

Biotest AG's quarterly buildings and improvements increased from Sep. 2023 (€0.0 Mil) to Dec. 2023 (€72.8 Mil) but then declined from Dec. 2023 (€72.8 Mil) to Mar. 2024 (€0.0 Mil).

Biotest AG's annual buildings and improvements increased from Dec. 2021 (€35.6 Mil) to Dec. 2022 (€41.5 Mil) and increased from Dec. 2022 (€41.5 Mil) to Dec. 2023 (€72.8 Mil).

Biotest AG Buildings And Improvements Historical Data

The historical data trend for Biotest AG's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Buildings And Improvements Chart

Biotest AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

Get a 7-Day Free Trial

29.00

32.30

35.60

41.50

72.80

Biotest AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buildings And Improvements	Get a 7-Day Free Trial															-	-	-	72.80	-

Biotest AG Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Biotest AG (XTER:BIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (XTER:BIO) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

BIO3:Germany BIO3:Austria

Address

Landsteinerstrasse 5, Dreieich, DEU, 63303

Website

https://www.biotest.com

Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.